News HCW Biologics Inc.

Equities

HCWB

US40423R1059

Market Closed - Nasdaq Other stock markets 04:30:00 2024-05-13 pm EDT			5-day change	1st Jan Change
1.12 ^USD	-0.88%		-12.50%	-8.57%

Apr. 01	HCW Biologics Inc. Reports Earnings Results for the Full Year Ended December 31, 2023	CI
Apr. 01	HCW Biologics Inc. Reports Earnings Results for the Fourth Quarter Ended December 31, 2023	CI

Summary

Unlock all the news on all businesses: Never miss an investment opportunity again!

100% Free Registration

HCW Biologics Inc. Reports Earnings Results for the Full Year Ended December 31, 2023	Apr. 01	CI
HCW Biologics Inc. Reports Earnings Results for the Fourth Quarter Ended December 31, 2023	Apr. 01	CI
HCW Biologics Reports Fourth Quarter 2023 and Fiscal Year End Financial Results And Business Highlights	Apr. 01	AQ
HCW Biologics Inc. announced that it has received $2.500005 million in funding	Feb. 19	CI
HCW Biologics Inc. Exercises Its Right to Terminate Its Credit Agreement	Jan. 12	CI
HCW Biologics Inc. Reports Earnings Results for the Third Quarter and Nine Months Ended September 30, 2023	Nov. 14	CI
Earnings Flash (HCWB) HCW BIOLOGICS Reports Q3 Revenue $853,102	Nov. 14	MT
HCW Biologics Reports Third Quarter 2023 Financial Results And Recent Business Highlights	Nov. 14	AQ
Investigator Sponsor of HCW Biologics’ Phase 1 Clinical Trial Presented Human Data Readout and Anti-Cancer Mechanism of Action of HCW9218 at 38th SITC Annual Meeting	Nov. 08	GL
HCW Biologics Inc. Announces Results from Preliminary Human Data Readout from an Ongoing Phase 1 Clinical Trial Sponsored by the University of Minnesota	Nov. 08	CI
HCW Biologics : First-in-Human Clinical Readout of HCW9218, SITC 2023	Nov. 06	PU
Masonic Cancer Center, University of Minnesota to Present Data in Poster Presentation Human Data Readout for Phase 1 Study to Evaluate HCW9218 in Solid Tumors at SITC 38th Annual Meeting	Nov. 01	GL
HCW Biologics Participating at H.C. Wainwright 25th Annual Global Investment Conference in New York on September 11 – 13, 2023	23-09-06	GL
HCW Biologics Inc. Reports Earnings Results for the Second Quarter and Six Months Ended June 30, 2023	23-08-11	CI
Earnings Flash (HCWB) HCW BIOLOGICS Reports Q2 Revenue $622,807	23-08-11	MT
HCW Biologics Reports Second Quarter 2023 Financial Results and Recent Business Highlights	23-08-11	AQ
Hcw Biologics Inc. Announces Appointment of Rick S. Greene as Class II Director	23-06-14	CI
HCW Biologics Says It Received Patent for Methods to Treat Diseases Caused by Chronic Inflammation	23-06-14	MT
HCW Biologics is Granted Third Fundamental Patent: U.S. Patent for Methods of Treating Age-Related Disorders	23-06-14	AQ
EF Hutton Assumes HCW Biologics at Buy With $9 Price Target	23-06-01	MT

No results for this search

All News Analyst Reco. Highlights Insiders Transcripts Press Releases Official Publications Other languages Trading Ideas MarketScreener Editorial Features MarketScreener Strategies

News HCW Biologics Inc.

Equities

HCWB

US40423R1059

Summary

Filters